The protective effect of carnosine on apoptosis in HBMEC induced by LPS and its mechanism

ZHAO Yan, HU Jing, YANG Wen-qiang, HE Xin, DU Jia-rui, LI Zong-ze, YANG Jing

Chinese Journal of Clinical Anatomy ›› 2019, Vol. 37 ›› Issue (2) : 174-178.

Chinese Journal of Clinical Anatomy ›› 2019, Vol. 37 ›› Issue (2) : 174-178. DOI: 10.13418/j.issn.1001-165x.2019.02.012

The protective effect of carnosine on apoptosis in HBMEC induced by LPS and its mechanism

  • ZHAO Yan1, HU Jing1, YANG Wen-qiang2, HE Xin2, DU Jia-rui2, LI Zong-ze2, YANG Jing2
Author information +
History +

Abstract

Objective To investigate the protective effect of carnosine on apoptosis in HBMEC induced by LPS and its mechanisms. Methods The injury model was established by treating HBMEC cells with LPS in vitro. Inverted microscope was used to observe cell morphology. The cell viability was detected by MTT assay, and the cell apoptosis rates were measured by flow cytometry. The reactive oxygen species (ROS) level in cells was detected by fluorescent probe CDFH-DA. The expressions of NF-κB P65, IL-1β and TNF-α were explored by Western blot. Results Compared with control group, the cell viability was slightly decreased in LPS group (P>0.05). The apoptosis rate, the level of ROS, nuclear NF-κB P65, IL-1β and TNF-α increased obviously (P<0.01) in LPS group. Compared with LPS group, the apoptosis rate, the level of ROS, nuclear NF-κB P65, IL-1β and TNF-α reduced obviously (P<0.01) in LPS+carnosine group (10mmol/L,20mmol/L,40 mmol/L). Conclusions Carnosine has protective effect on apoptosis of HBMEC cells injury induced by LPS. The mechanism may be related that carnosine inhibited LPS induced ROS production, avoided NF-κB pathway overactivation, and further decreased the secretion of IL-1β and TNF-α.

Key words

Carnosine /  LPS /  HBMEC cells /  Apoptosis /  NF-&kappa / B

Cite this article

Download Citations
ZHAO Yan, HU Jing, YANG Wen-qiang, HE Xin, DU Jia-rui, LI Zong-ze, YANG Jing. The protective effect of carnosine on apoptosis in HBMEC induced by LPS and its mechanism[J]. Chinese Journal of Clinical Anatomy. 2019, 37(2): 174-178 https://doi.org/10.13418/j.issn.1001-165x.2019.02.012

References

[1]   Tabit CE, Chung WB, Hamburg NM, et al. Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications[J]. Rev Endocr Metab Disord, 2010, 11(1): 61-74.
[2]  Liu D, Zhang D, Scafidi J, et al. C1 inhibitor prevents Gram-negative bacterial lipopolysaccharide-induced vascular permeability[J]. Blood, 2005, 105(6): 2350-2355.
[3]   赵艳, 赵颂, 李晴, 等. 肌肽对谷氨酸诱导SH-SY5Y细胞凋亡的保护作用[J]. 中国生化药物杂志, 2015, 35(12): 34-37.
[4]  方超, 李晴, 鲁美丽, 等. 肌肽对大鼠脑片缺氧/再灌损伤的保护作用[J]. 中国生化药物杂志,2015,35(9):41-47.
[5]  赵丹婷, 刘影, 赵艳, 等. 肌肽对糖尿病大鼠海马中氧化应激及NF-κB信号通路的影响[J]. 中国临床解剖学杂志, 2018, 36(5): 514-519.
[6]  Sun YX, Ge X, Li M, et al. Dyrk2 involved in regulating LPS-induced neuronal apoptosis[J]. Int J Biol Macromol, 2017, 104(Pt A): 979-986.
[7]  Li C, Ma D, Chen M, et al. Ulinastatin attenuates LPS-induced human endothelial cells oxidative damage through suppressing JNK/c-Jun signaling pathway[J]. Biochem Biophys Res Commun, 2016, 474(3): 572-578.
[8]  Sun X, Yang Y, Shi J, et al. NOX4- and Nrf2-mediated oxidative stress induced by silver nanoparticles in vascular endothelial cells[J]. J Appl Toxicol, 2017, 37(12): 1428-1437.
[9] Ridker PM, Everett BM, Thuren T, et al. CANTOS Trial Group. Antiinflammatory therapy with canakinumab for atherosclerotic disease[J]. N Engl J Med, 2017, 377(12): 1119-1131.

Accesses

Citation

Detail

Sections
Recommended

/